Differentiation of human alloreactive CD8(+) T cells in vitro

Rob J Rentenaar1, Jelle L G Vosters, Frank N J van Diepen

  • 1Renal Transplant Unit, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. rrentenaar@yahoo.com

Immunology
|March 29, 2002
PubMed

Insights

This study tracked CD8(+) T cell proliferation and differentiation in mixed lymphocyte cultures. While in vitro methods visualized alloantigen-specific CD8(+) T cells, they failed to detect activated cells in vivo after kidney transplantation.

Area of Science:

  • Immunology
  • Cellular immunology
  • Transplantation immunology

Background:

  • CD8(+) T cells play a crucial role in immune responses, including allograft rejection.
  • Understanding the expansion and differentiation of alloantigen-reactive CD8(+) T cells is vital for managing transplant outcomes.

Purpose of the Study:

  • To investigate the proliferation and differentiation kinetics of alloantigen-reactive CD8(+) T cells in vitro.
  • To assess the utility of in vitro methods for detecting in vivo activated alloreactive CD8(+) T cells.

Main Methods:

  • Mixed lymphocyte cultures (MLC) were used to stimulate T cells.
  • Carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution was measured to assess T cell proliferation.
  • Flow cytometry was employed to analyze T cell differentiation markers (CD45RA, CD27) and intracellular cytokine production (interferon-gamma).

Main Results:

  • CD8(+) T cell proliferation was detectable by day 4 in MLC, with over 60% dividing by day 6.
  • Differentiation was evidenced by decreased CD45RA and CD27 expression and acquisition of interferon-gamma production.
  • In vitro methods successfully visualized expanded alloantigen-reactive CD8(+) T cells but failed to detect activated cells in vivo in kidney transplant recipients.

Conclusions:

  • Short-term in vitro stimulation and cytokine measurement can visualize alloantigen-specific CD8(+) T cells.
  • Current in vitro techniques may not be sensitive enough to detect circulating alloreactive CD8(+) T cells activated in vivo following allogeneic kidney transplantation.